Virtu Financial’s Terns Pharmaceuticals TERN Stock Holding History

Virtu Financial’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,715	Closed	-$3.73M	–	2235
2026 Q1	$3.73M	Buy	+70,715	New	+$2.9M	0.15%	77
2024 Q4	–	Sell	-62,216	Closed	-$519K	–	2043
2024 Q3	$519K	Buy	62,216 +32,624	+110%	+$268K	0.03%	443
2024 Q2	$202K	Sell	29,592 -14,715	-33%	-$89.1K	0.01%	708
2024 Q1	$291K	Buy	+44,307	New	+$289K	0.02%	625

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtu Financial's TERN Position: Q2 2026 in Review

Virtu Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 70,715 shares — an estimated $3.73M sold.

Virtu Financial first reported a position in TERN in Q1 2024 and held it in 4 quarters. The position peaked at $3.73M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Virtu Financial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 70,715 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.73M.
Virtu Financial first reported a position in Terns Pharmaceuticals in Q1 2024 and held it in 4 quarters.
Virtu Financial's Terns Pharmaceuticals position peaked at $3.73M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.